Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - iron (iii) hydroxide polymaltose complex -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

unimed sdn bhd - iron (iii) hydroxide polymaltose complex -

Kenya - English - Pharmacy and Poisons Board

emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex & folic… - capsule - iron (iii) hydroxide polymaltose complex… - antianemic preparations - iron preparations: iron

Israel - English - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - tablets - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.

Israel - English - Ministry of Health

cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 20 mg/ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)

Israel - English - Ministry of Health

cts ltd - ferrous as iron iii hydroxide sucrose complex - solution for injection - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - iron-sorbitol-citric acid complex - iron-sorbitol-citric acid complex - venofer is indicated for the treatment of iron deficiency in the following indications:• where there is a clinical need for a rapid iron supply,• in patients who cannot tolerate oral iron therapy or who are non-compliant,• in active inflammatory bowel disease where oral iron preparations are ineffective,• in chronic kidney disease when oral iron preparations are less effective.the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. hb, serum ferritin, tsat, serum iron, etc.)(hb haemoglobin, tsat transferrin saturation)

Australia - English - Department of Health (Therapeutic Goods Administration)

vifor pharma pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).

Israel - English - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl. - syrup - ferrous as iron iii hydroxide polymaltose compl. 50 mg / 5 ml - iron in other combinations - prevention and treatment of iron deficiency anaemia.

Israel - English - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl. - drops - ferrous as iron iii hydroxide polymaltose compl. 50 mg/ml - iron in other combinations - prevention and treatment of iron deficiency anaemia.

Kenya - English - Pharmacy and Poisons Board

emcure pharmaceuticals ltd t 184, midc, bhosari, pune, maharashtra 411026, - iron iii hydroxide polymaltose complex + folic… - tablet - iron (iii) hydroxide polymaltose complex(as… - drugs for functional gastrointestinal disorders: